Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the Loughborough Science Park. To date Nemuara has patents secured or pending in multiple countries across more than 15 patent families and over 80 individual patents, it also has an impressive pipeline of drugs under pre-clinical and clinical development, with an ANDA under review by FDA for a Blockbuster drug, and a spin out technology floated on the US Stock Exchange, (NASDAQ: NMRD). www.nemaura.co.uk